Live feed
Filing
SC 13D
SC 13D0001214659-24-016381·Aurinia Pharmaceuticals Inc.
Schedule 13D ownership disclosure
Aurinia Pharmaceuticals Inc
Security class unavailable · CUSIP: 05156V102
Event date: 2024-09-06
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001214659-24-016381
- Form type
- SC 13D
- Filer
- Aurinia Pharmaceuticals Inc.
- CIK
- CIK 1600620
- Filed
- Sep 12, 2024
- Reporting period
- Sep 06, 2024
- Description
- Schedule 13D beneficial ownership